0001387131-12-004137.txt : 20121227
0001387131-12-004137.hdr.sgml : 20121227
20121227145028
ACCESSION NUMBER: 0001387131-12-004137
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20121227
DATE AS OF CHANGE: 20121227
EFFECTIVENESS DATE: 20121227
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tamir Biotechnology, Inc.
CENTRAL INDEX KEY: 0000708717
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222369085
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-189029
FILM NUMBER: 121287289
BUSINESS ADDRESS:
STREET 1: 300 ATRIUM DRIVE
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: 732-652-4525
MAIL ADDRESS:
STREET 1: 300 ATRIUM DRIVE
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: ALFACELL CORP
DATE OF NAME CHANGE: 19920703
D
1
primary_doc.xml
X0706
D
LIVE
0000708717
Tamir Biotechnology, Inc.
11 DEER PARK DRIVE
SUITE 204, PRINCETON CORPORATE PLAZA
MONMOUTH JUNCTION
NJ
NEW JERSEY
08853
732-823-1003
DELAWARE
Alfacell Corp.
ALFACELL CORP
Corporation
true
David
Sidrandky
c/o Tamir Biotechnology, Inc
11 DEER PARK DRIVE,SUITE 204, PRINCETON
Monmouth Junction
NJ
NEW JERSEY
08853
Director
John
P.
Brancaccio
c/o Tamir Biotechnology, Inc
11 DEER PARK DRIVE,SUITE 204, PRINCETON
Monmouth Junction
NJ
NEW JERSEY
08853
Director
Paul
M.
Weiss
c/o Tamir Biotechnology, Inc
11 DEER PARK DRIVE,SUITE 204, PRINCETON
Monmouth Junction
NJ
NEW JERSEY
08853
Director
Charles
Muniz
c/o Tamir Biotechnology, Inc
11 DEER PARK DRIVE,SUITE 204, PRINCETON
Monmouth Junction
NJ
NEW JERSEY
08853
Director
Lawrence
A.
Kenyon
Tamir Biotechnology, Inc
11 DEER PARK DRIVE,SUITE 204, PRINCETON
Monmouth Junction
NJ
NEW JERSEY
08553
Executive Officer
Biotechnology
Decline to Disclose
- 06
false
2012-12-14
false
true
true
false
15000
None
None
None
None
NONE
NONE
NONE
NJ
NEW JERSEY
None
NJ
NEW JERSEY
false
1000000
1000000
0
false
5
0
0
0
false
Tamir Biotechnology, Inc.
Lawrence A. Kenyon
Lawrence A. Kenyon
Chief Executive Officer and Chief Financial Officer
2012-12-27